1Ishida H,Ishida Y,Kurosaka Y,et al.In vitro and in vivo activities of levofloxacin against biofilm-producing pseudomonas aeruginosa.Antimicrob Agents Chemother,1998;42:1641
2Marc Habash MSC Reid G.MBA microbial biofilms:their development and significance for medical device-related infections.J Clin Pharmacol,1999;39:887
3Costerton JW,Stewart PS,Greenberg EP.Bacterial biofilms:a common cause of persistent infection.Science,1999;284;1318
4Stenberg C,Christensen BB,Johansen J,et al.Distribution of bacterial growth activities in flow chamber biofilm.Appl Environ Microbiol,1999;65:4108
5Karen D,Xu KD.Biofilm resistance to antimicrobial agents.Microbiology,2000;13:146
4NCCLS. M2 A8 Performance standards for antimicrobial disk sus eeptibility test : approved standard[S]. NCCLS, 2003 : 100.
5Majed M, MasadhNizar M, Alzoubi KH, et all. In vitro determina- tion of the antibiotic susceptibility of biofilm forming Pseudo- monas aeruginosa and Staphylococcus aureus: possible role of proteolytie activity and membrane lipopolysaccharide[J]. Infect Drug Resist,2013,6(1) :27-32.
6Kadar B,Kocsis B, Nagy K, et al. The renaissance of polymyxins [J]. Curt Med Chem,2013,20(30) ,3759-3773.
8Stepanovies,Vukovied,Holav,et al.Quantification of biofilm in microtiter plates:overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci[J].APMIS,2007,115(8):891-899.
9National Committee for Clinical Laboratory Standards.Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically:approved standard M7-A5.Wayne PA:NCCLS,2003.
10Xiaoqing Wang,Xiao Yao,Zhen'an Zhu,et al.Effect of berberine on Staphylococcus epidermidis biofilm formation[J].INT J ANTIMICROB AG,2009,34:60-66.
